Alberto Gabizon

发表

Pharmacokinetics of Pegylated Liposomal Doxorubicin

Yechezkel Barenholz, Y. Barenholz, H. Shmeeda, 2003, Clinical pharmacokinetics.

Controlling liposomal drug release with low frequency ultrasound: mechanism and feasibility.

Joseph Kost, Yechezkel Barenholz, J. Kost, 2007, Langmuir : the ACS journal of surfaces and colloids.

Liposome imaging agents in personalized medicine.

Thomas L Andresen, A. Gabizon, T. Andresen, 2012, Advanced drug delivery reviews.

Pharmacological basis of pegylated liposomal doxorubicin: impact on cancer therapy.

H. Shmeeda, A. Gabizon, Alberto Gabizon, 2012, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Dose Dependency of Pharmacokinetics and Therapeutic Efficacy of Pegylated Liposomal Doxorubicin (DOXIL) in Murine Models

D. Tzemach, A. Gabizon, Alberto Gabizon, 2002, Journal of drug targeting.

Tumor cell targeting of liposome-entrapped drugs with phospholipid-anchored folic acid-PEG conjugates.

Samuel Zalipsky, H. Shmeeda, A. Gabizon, 2004, Advanced drug delivery reviews.

Integrating Nanotechnology into Cancer Care.

Michael S. Goldberg, Piotr Grodzinski, P. Grodzinski, 2019, ACS nano.

Alteration of blood-brain-CSF barrier in experimental meningeal carcinomatosis

A. Gabizon, T. Siegal, Alberto Gabizon, 1987, Journal of Neuro-Oncology.

In vivo fate of folate-targeted polyethylene-glycol liposomes in tumor-bearing mice.

Samuel Zalipsky, H. Shmeeda, D. Tzemach, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

Cancer nanomedicines: closing the translational gap

Michelle Bradbury, Piotr Grodzinski, S. Libutti, 2014, The Lancet.

Her2-targeted pegylated liposomal doxorubicin: retention of target-specific binding and cytotoxicity after in vivo passage.

H. Shmeeda, D. Tzemach, L. Mak, 2009, Journal of controlled release : official journal of the Controlled Release Society.

Initial Clinical Evaluation of Pegylated-Liposomal Doxorubicin in Solid Tumors

A. Gabizon, F. Muggia, Alberto Gabizon, 1998 .

Activation of complement by therapeutic liposomes and other lipid excipient-based therapeutic products: prediction and prevention.

Yechezkel Barenholz, Janos Szebeni, Y. Barenholz, 2011, Advanced drug delivery reviews.

Mechanisms and Barriers in Cancer Nanomedicine: Addressing Challenges, Looking for Solutions.

Dan Peer, Biana Godin, Ji-Ho Park, 2017, ACS nano.

Liposome circulation time and tumor targeting: implications for cancer chemotherapy

A. Gabizon, Alberto Gabizon, 1995 .

Ultrasound triggered release of cisplatin from liposomes in murine tumors.

Joseph Kost, Yechezkel Barenholz, J. Kost, 2009, Journal of controlled release : official journal of the Controlled Release Society.

Fabrication Principles and Their Contribution to the Superior In Vivo Therapeutic Efficacy of Nano-Liposomes Remote Loaded with Glucocorticoids

Yechezkel Barenholz, Alex Sigal, A. Sigal, 2011, PloS one.

Intracellular uptake and intracavitary targeting of folate-conjugated liposomes in a mouse lymphoma model with up-regulated folate receptors

H. Shmeeda, D. Tzemach, A. Gabizon, 2006, Molecular Cancer Therapeutics.

Reduced UV-Induced Degradation of Doxorubicin Encapsulated in Polyethyleneglycol-Coated Liposomes

Yechezkel Barenholz, Y. Barenholz, A. Gabizon, 1999, Pharmaceutical Research.

Exploiting the Metal-Chelating Properties of the Drug Cargo for In Vivo Positron Emission Tomography Imaging of Liposomal Nanomedicines

John Maher, Lefteris Livieratos, Istvan Szanda, 2016, ACS nano.